Neil Woodhams, President of MSNZ, welcomed the interim findings of the Pharmac Review released last week. The full report can be found here: https://pharmacreview.health.govt.nz › interim-report.
The report highlights the problems MSNZ has experienced over many years in its dealings with PHARMAC, over access to world-class treatments for MS. The length of time taken to make decisions, the lack of transparency in processes, the undue delays in decision making and an emphasis on cost saving to PHARMAC are all things we have experienced in our dealings with PHARMAC.
MSNZ looks forward to the final report and the solutions proposed to address these issues.